Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Ciulli

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Journal of the American Chemical Society|June 28, 2018
3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein DegradationAndrea Testa, Xavier Lucas, Guilherme V Castro, et al.
Science (New York, N.Y.)|October 18, 2014
Chemical biology. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probesMatthias G J Baud, Enrique Lin-Shiao, Teresa Cardote, et al.
Leukemia|March 12, 2025
Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617FMarc Usart, Quentin Kimmerlin, Jan Stetka, et al.
Nature Communications|November 5, 2016
Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibitionJulianty Frost, Carles Galdeano, Pedro Soares, et al.
Oncogene|May 7, 2021
Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanomaSilvia Pietrobono, Eugenio Gaudio, Sinforosa Gagliardi, et al.
Nature Communications|July 15, 2026
Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTACCarlo J A Verhoef, Charlotte Crowe, Mark A Nakasone, et al.
British Journal of Pharmacology|April 6, 2017
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approachAli Ryan, Elena Polycarpou, Nathan A Lack, et al.
Nature Communications|June 30, 2026
Targeted Protein Degradation of NUDT5 Dissociates Catalytic Inhibition from Protein Loss in 6-Thioguanine ResponseAnne-Sophie M C Marques, Ludwig G Bauer, Tuan-Anh Nguyen, et al.
Nature Chemical Biology|May 12, 2026
Dual E3 ligase recruitment by monovalent degraders for tunable SMARCA 2/4 degradationValentina A Spiteri, Dmitri Segal, Alejandro Correa-Sáez, et al.
The Biochemical Journal|November 19, 2015
Biophysical characterization of laforin-carbohydrate interactionDavid M Dias, Joana Furtado, Emeric Wasielewski, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Journal of the American Chemical Society|June 28, 2018
3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein DegradationAndrea Testa, Xavier Lucas, Guilherme V Castro, et al.
Science (New York, N.Y.)|October 18, 2014
Chemical biology. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probesMatthias G J Baud, Enrique Lin-Shiao, Teresa Cardote, et al.
Leukemia|March 12, 2025
Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617FMarc Usart, Quentin Kimmerlin, Jan Stetka, et al.
Nature Communications|November 5, 2016
Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibitionJulianty Frost, Carles Galdeano, Pedro Soares, et al.
Oncogene|May 7, 2021
Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanomaSilvia Pietrobono, Eugenio Gaudio, Sinforosa Gagliardi, et al.
Nature Communications|July 15, 2026
Induced ubiquitination of the partially disordered estrogen receptor alpha via a 14-3-3 directed molecular glue-PROTACCarlo J A Verhoef, Charlotte Crowe, Mark A Nakasone, et al.
British Journal of Pharmacology|April 6, 2017
Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approachAli Ryan, Elena Polycarpou, Nathan A Lack, et al.
Nature Communications|June 30, 2026
Targeted Protein Degradation of NUDT5 Dissociates Catalytic Inhibition from Protein Loss in 6-Thioguanine ResponseAnne-Sophie M C Marques, Ludwig G Bauer, Tuan-Anh Nguyen, et al.
Nature Chemical Biology|May 12, 2026
Dual E3 ligase recruitment by monovalent degraders for tunable SMARCA 2/4 degradationValentina A Spiteri, Dmitri Segal, Alejandro Correa-Sáez, et al.
The Biochemical Journal|November 19, 2015
Biophysical characterization of laforin-carbohydrate interactionDavid M Dias, Joana Furtado, Emeric Wasielewski, et al.
Pageof 15